| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Venus Concept Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
| 03.02. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.01. | Venus Concept Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
| 21.01. | Why Is Venus Concept Stock Plunging Today? | 3 | Benzinga.com | ||
| 21.01. | Venus Concept to voluntarily delist from Nasdaq and deregister with SEC; shares tumble | 5 | Seeking Alpha | ||
| 21.01. | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| VENUS CONCEPT Aktie jetzt für 0€ handeln | |||||
| 21.01. | Venus Concept Inc.: Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC | 141 | GlobeNewswire (Europe) | TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market... ► Artikel lesen | |
| 16.01. | Venus Concept Stock Explodes Over 500% After Major Investor Takes Control | 37 | Benzinga.com | ||
| 07.01. | Venus Concept Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 02.12.25 | Venus Concept Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 13.11.25 | Venus Concept targets sequential Q4 growth with Venus NOVA launch amid Venus Hair sale uncertainty | 6 | Seeking Alpha | ||
| 13.11.25 | Venus Concept Inc. Q3 Sales Decline | 3 | RTTNews | ||
| 13.11.25 | Venus Concept GAAP EPS of -$12.14, revenue of $13.78M | 9 | Seeking Alpha | ||
| 13.11.25 | Venus Concept Inc.: Venus Concept Announces Third Quarter 2025 Financial Results | 349 | GlobeNewswire (Europe) | TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen | |
| 13.11.25 | Venus Concept Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11.25 | Venus Concept Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.11.25 | Venus Concept Inc.: Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments | 241 | GlobeNewswire (Europe) | TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance... ► Artikel lesen | |
| 31.10.25 | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.10.25 | Venus Concept announces $11.48 million debt-to-equity exchange transaction | 2 | Seeking Alpha | ||
| 02.10.25 | Venus Concept Inc.: Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction | 169 | GlobeNewswire (Europe) | TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 50,20 | +0,36 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
05.02.2026 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,350 | +1,41 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,180 | +0,80 % | Picks and shovels play intact, chg.: FY25 prelims confirm Eckert & Ziegler's earnings momentum, with China and isotope ... | Novo Nordisk's c.17% share price drop underscores how quickly sentiment can turn in single product healthcare stories, especially when patent cycle concerns resurface. In contrast, EUZ is "picks and... ► Artikel lesen | |
| UNITEDHEALTH | 229,80 | -0,65 % | Märkte am Morgen: Bitcoin rauscht ab - Gold, Silber, Strategy, Amazon, UnitedHealth, SAP, Bayer | Der DAX kommt weiter nicht in die Gänge. Gestern startete der Leitindex zwar ordentlich, rutschte dann aber deutlich ab. Immerhin reduzierte er seine Verluste kurz vor Handelsende etwas. Heute deuten... ► Artikel lesen | |
| THERMO FISHER | 453,30 | -1,21 % | Thermo Fisher Prices $3.8 Bln Senior Notes To Fund Clario Acquisition | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO), a life science and clinical research company, on Tuesday announced it has priced a $3.8 billion senior notes offering to partially... ► Artikel lesen | |
| TELADOC HEALTH | 4,083 | -2,40 % | Teladoc Health, Inc.: Teladoc Health to Announce Fourth Quarter 2025 Financial Results | ||
| ROKU | 76,75 | +3,33 % | Your Roku just got a free upgrade that could save you money - no Roku TV required | ||
| HIMS & HERS HEALTH | 14,465 | -10,96 % | Hims & Hers-Aktie -10%: Warum profitiert sie nicht? | Die Hims & Hers-Aktie schoss am gestrigen Donnerstag kurzfristig um über +10% in die Höhe, beendete den Handelstag dann aber doch mit einem Minus von fast -4%. Am Freitagmorgen bricht der Kurs der Gesundheitsplattform... ► Artikel lesen | |
| BICO GROUP | 1,663 | +2,91 % | BICO Group AB: BICO company Biosero launches GoSimple, a standardized automation-ready workcell with selected instruments from Sartorius and Becton, Dickinson and Company (BD) | Biosero, part of the BICO Group and a leader in lab automation, will launch the GoSimple workcell at SLAS 2026 (February 7-11, Boston, US). GoSimple is a standardized, automation-ready workcell designed... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,265 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Provides Business Update on REYOBIQ Clinical Program and U.S. CNSide Commercialization | HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| RESMED | 225,40 | -2,72 % | RESMED INC: 144 Report of proposed sale of securities | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | XFRA 7300,B0Y,YAG: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZEROSTACK CORP.... ► Artikel lesen | |
| HENRY SCHEIN | 65,54 | -2,53 % | Henry Schein Allows KKR To Buy Up To 19.9% Of Stake, Lifts Annual Outlook; Stock Up Over 8% | MELVILLE (dpa-AFX) - Henry Schein, Inc. (HSIC), a distributor of health care products and services, said on Tuesday that its Board has approved an amendment to the strategic partnership agreement... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,860 | +0,15 % | Siemens Healthineers AG: SHL verzeichnet einen soliden Start, während China weiterhin eine Belastung darstellt. KAUFEN. | Siemens Healthineers (SHL) hat im ersten Quartal des Geschäftsjahres 2026 solide Ergebnisse geliefert und die Prognose trotz anhaltender Schwäche in China bestätigt. Der Umsatz stieg im Vergleich zum... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,630 | -0,77 % | 6 Analysts Have This To Say About Alignment Healthcare |